BCAX Form 144: Sale notice for 28,750 shares

BCAX filed a Form 144 notice reporting the sale of 28,750 shares.

Accepted by SEC EDGAR 07/08/2026 - 04:11 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

BCAX filed a Form 144 notice reporting the sale of 28,750 shares. The filing lists two planned or reported option exercises: 10,000 shares exercised on 05/12/2024 and 18,750 shares exercised on 07/08/2026. The filing also reports two sales during the past three months: 12,500 shares sold on 04/15/2026 for $287,591.25 and 12,500 shares sold on 05/15/2026 for $253,648.75.

Key Figures

Total shares reported for sale: 28,750 shares Option exercise (May 12, 2024): 10,000 shares Option exercise (Jul 08, 2026): 18,750 shares +2 more

5 metrics

Total shares reported for sale 28,750 shares sum of 10,000 and 18,750 listed under "Securities To Be Sold"

Option exercise (May 12, 2024) 10,000 shares Exercise of Stock Option on <date>05/12/2024</date>

Option exercise (Jul 08, 2026) 18,750 shares Exercise of Stock Option on <date>07/08/2026</date>

Sale on April 15, 2026 12,500 shares for $287,591.25 Reported under "Securities Sold During The Past 3 Months"

Sale on May 15, 2026 12,500 shares for $253,648.75 Reported under "Securities Sold During The Past 3 Months"

Key Terms

Form 144, Exercise of Stock Option, Securities Sold During The Past 3 Months

3 terms

Form 144 regulatory

"144: Filer Information | 144: Securities To Be Sold"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Exercise of Stock Option financial

"Common | 05/12/2024 | Exercise of Stock Option"

Securities Sold During The Past 3 Months regulatory

"144: Securities Sold During The Past 3 Months | Common | 05/15/2026"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does BCAX's Form 144 report show?

It reports a sale notice totaling 28,750 shares. The filing itemizes option exercises of 10,000 on 05/12/2024 and 18,750 on 07/08/2026, plus two recent sales of 12,500 shares each on 04/15/2026 and 05/15/2026 with stated proceeds.

Who executed the recent sales listed in the BCAX filing?

The filing identifies Ryan Cohlhepp as the seller for two recent transactions. It shows sales of 12,500 shares on 04/15/2026 for $287,591.25 and 12,500 shares on 05/15/2026 for $253,648.75, as disclosed in the Form 144 excerpt.

Do the entries show option exercises related to the BCAX sale notice?

Yes. The filing links option exercises to the reported shares. It records an exercise of 10,000 shares on 05/12/2024 and another exercise of 18,750 shares on 07/08/2026, both labeled "Exercise of Stock Option" and "Cash".

Are proceeds or prices provided for the recent BCAX sales?

Yes. The filing lists dollar proceeds for the two recent sales. It reports $287,591.25 for 12,500 shares on 04/15/2026 and $253,648.75 for 12,500 shares on 05/15/2026 in the Form 144 excerpt.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002034665
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Bicara Therapeutics Inc.
SEC File Number	001-42271
Address of Issuer	116 HUNTINGTON AVENUE SUITE 703 BOSTON MASSACHUSETTS 02116
Phone	617-468-4219
Name of Person for Whose Account the Securities are To Be Sold	Cohlhepp Ryan
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	UBS Financial Services, Inc Eleven Madison Avenue 4th Floor New York NY 10010	28750	869687.50	65703866	07/08/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	05/12/2024	Exercise of Stock Option	Issuer			10000	05/12/2024	Cash
Common	07/08/2026	Exercise of Stock Option	Issuer			18750	07/08/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Ryan Cohlhepp 116 HUNTINGTON AVENUE, SUITE 703 Boston MA 02116	Common	05/15/2026	12500	253648.75
Ryan Cohlhepp 116 HUNTINGTON AVENUE, SUITE 703 Boston MA 02116	Common	04/15/2026	12500	287591.25

144: Remarks and Signature

Remarks
Date of Notice	07/08/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	03/31/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ UBS Financial Services Inc., as attorney-in-fact for Ryan Cohlhepp
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)